Connecticut Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.7M Buy
4,018
+55
+1% +$55.8K 0.15% 72
2025
Q4
$4.26M Buy
3,963
+263
+7% +$251K 0.19% 63
2025
Q3
$2.82M Buy
3,700
+1,258
+52% +$936K 0.13% 77
2025
Q2
$1.9M Buy
2,442
+1
+0% +$777 0.09% 97
2025
Q1
$2.02M Buy
2,441
+3
+0.1% +$2.5K 0.11% 94
2024
Q4
$1.88M Sell
2,438
-543
-18% -$450K 0.09% 87
2024
Q3
$2.64M Sell
2,981
-219
-7% -$197K 0.13% 86
2024
Q2
$2.9M Buy
3,200
+158
+5% +$126K 0.15% 79
2024
Q1
$2.37M Buy
3,042
+2
+0.1% +$1.42K 0.13% 86
2023
Q4
$1.77M Buy
3,040
+154
+5% +$89.9K 0.1% 95
2023
Q3
$1.55M Buy
2,886
+1,029
+55% +$530K 0.11% 88
2023
Q2
$871K Buy
1,857
+445
+32% +$187K 0.06% 105
2023
Q1
$485K Buy
1,412
+355
+34% +$120K 0.04% 140
2022
Q4
$387K Sell
1,057
-42
-4% -$14.9K 0.03% 130
2022
Q3
$355K Sell
1,099
-11
-1% -$3.48K 0.03% 131
2022
Q2
$360K Sell
1,110
-32
-3% -$9.61K 0.03% 139
2022
Q1
$327K Buy
1,142
+15
+1% +$3.86K 0.03% 146
2021
Q4
$311K Sell
1,127
-17
-1% -$4.31K 0.02% 158
2021
Q3
$264K Buy
1,144
+110
+11% +$27.1K 0.02% 170
2021
Q2
$237K Sell
1,034
-4,884
-83% -$981K 0.02% 172
2021
Q1
$1.11M Buy
5,918
+2
+0% +$391 0.1% 63
2020
Q4
$999K Buy
5,916
+2
+0% +$299 0.11% 75
2020
Q3
$875K Buy
+5,914
New +$915K 0.1% 89

Other funds holding LLY

Connecticut Wealth Management's LLY Position: Q1 2026 in Review

Connecticut Wealth Management increased its Eli Lilly (LLY) stake by 1.4% in Q1 2026, buying an estimated $55.8K and bringing the position to 4,018 shares worth $3.7M. The position accounts for 0.15% of the portfolio, ranked #72.

Connecticut Wealth Management first reported a position in LLY in Q3 2020 and has held it in 23 quarters since. The position peaked at $4.26M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Connecticut Wealth Management held 4,018 shares of Eli Lilly worth $3.7M as of Q1 2026.
  • Connecticut Wealth Management bought 55 Eli Lilly shares in Q1 2026, an estimated $55.8K.
  • Eli Lilly made up 0.15% of Connecticut Wealth Management's portfolio in Q1 2026, its #72 holding.
  • Connecticut Wealth Management first reported a position in Eli Lilly in Q3 2020 and has held it in 23 quarters since.
  • Connecticut Wealth Management's Eli Lilly position peaked at $4.26M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Connecticut Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.